https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-30 / Physiol Res 2008;57(3):459-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-30 / Physiol Res 2008;57(3):459-652007-05-30 00:00:002007-05-30 00:00:00Immunological response in the mouse melanoma model after local hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-432007-05-24 00:00:002019-02-15 09:03:02Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-16 / Lung Cancer 2007 Sep;57(3):365-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-16 / Lung Cancer 2007 Sep;57(3):365-722007-05-16 00:00:002019-02-15 08:45:36Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Int J Hyperthermia 2007 May;23(3):267-75
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Int J Hyperthermia 2007 May;23(3):267-752007-05-01 00:00:002019-02-15 08:35:05Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Int J Hyperthermia 2007 May;23(3):303-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Int J Hyperthermia 2007 May;23(3):303-142007-05-01 00:00:002019-02-15 08:35:25On verification of hyperthermia treatment planning for cervical carcinoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-932007-05-01 00:00:002019-02-15 09:24:06TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-62007-05-01 00:00:002019-02-15 09:24:07[Changes of dendritic cells in prostate cancer and dendritic cell-based immunotherapy]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-37
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-372007-05-01 00:00:002019-02-15 09:11:47AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Lancet Oncol. 2007 May;8(5):451-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Lancet Oncol. 2007 May;8(5):451-42007-05-01 00:00:002007-05-01 00:00:00Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-20 / Clin. Immunol. 2007 Jun;123(3):298-310
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-20 / Clin. Immunol. 2007 Jun;123(3):298-3102007-04-20 00:00:002019-02-15 09:16:58Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression
